These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 21502249

  • 1. Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration.
    Ball R, Horne D, Izurieta H, Sutherland A, Walderhaug M, Hsu H.
    Pediatrics; 2011 May; 127 Suppl 1():S31-8. PubMed ID: 21502249
    [Abstract] [Full Text] [Related]

  • 2. Food and Drug Administration regulation and evaluation of vaccines.
    Marshall V, Baylor NW.
    Pediatrics; 2011 May; 127 Suppl 1():S23-30. PubMed ID: 21502242
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development and approval of vaccines in the United States.
    Botstein P.
    Isr J Med Sci; 1986 May; 22(3-4):268-71. PubMed ID: 3528047
    [Abstract] [Full Text] [Related]

  • 6. Bolstering the FDA's drug-safety authority.
    Schultz WB.
    N Engl J Med; 2007 Nov 29; 357(22):2217-9. PubMed ID: 18046024
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. How can you promote vaccine safety?
    Miller ER, Iskander J, Pickering S, Varricchio F.
    Nursing; 2007 Apr 29; 37(4):58-63; quiz 63-4. PubMed ID: 17413371
    [No Abstract] [Full Text] [Related]

  • 15. The complicated task of monitoring vaccine safety.
    Ellenberg SS, Chen RT.
    Public Health Rep; 1997 Apr 29; 112(1):10-20; discussion 21. PubMed ID: 9018282
    [Abstract] [Full Text] [Related]

  • 16. Policy developments in regulatory approval.
    Temple R.
    Stat Med; 2002 Oct 15; 21(19):2939-48. PubMed ID: 12325110
    [Abstract] [Full Text] [Related]

  • 17. Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.
    Kesselheim AS, Mello MM.
    Health Aff (Millwood); 2007 Oct 15; 26(2):483-91. PubMed ID: 17339677
    [Abstract] [Full Text] [Related]

  • 18. Lessons learned from independent central review.
    Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.
    Eur J Cancer; 2009 Jan 15; 45(2):268-74. PubMed ID: 19101138
    [Abstract] [Full Text] [Related]

  • 19. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA.
    Pediatrics; 2011 May 15; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [Abstract] [Full Text] [Related]

  • 20. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR.
    Food Drug Law J; 2009 May 15; 64(1):183-223. PubMed ID: 19998746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.